Evaluation of warfarin dosing by pharmacists for elderly medical in-patients

Pharmacy World and Science

Volumn 26, Issue 4, 2004, Pages 232-237

  Burns, Naomi ^a  

^a BRIGHTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anti coagulation; Effectiveness; Evaluation; Guideline adherence; In patients; Pharmacist prescribing; United Kingdom; Warfarin

Indexed keywords

WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG FATALITY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; MEDICAL DOCUMENTATION; MEDICAL STAFF; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; RECTUM HEMORRHAGE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STROKE; WARD;

AGED; ATTITUDE OF HEALTH PERSONNEL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; INJECTIONS; INPATIENTS; INTERNATIONAL NORMALIZED RATIO; MEDICAL STAFF, HOSPITAL; MEDICATION ERRORS; OUTPATIENTS; PHARMACISTS; PRACTICE GUIDELINES; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 4043089984     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000035885.00408.9e     Document Type: Article

References (14)

1. Sinha U, Raha S, Wilkins E. Adverse drug reactions and hospital admission of older patients [letter]. Age Ageing 2000; 29: 551-2.
2. Lee Y, Schommer JC. Effect of a pharmacist managed anti-coagulant clinic on warfarin related hospital re-admissions. Am J Health Syst Pharm 1996; 53: 1580-3.
3. Medication Error Review Group. Medication error report. Brighton Health Care NHS Trust 1999.
4. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anti-coagulation clinic. Drug Intell Clin Pharm 1985; 19: 575-80.
5. Cohen IA, Hutchison TA, Kirking DM, Shue ME. Evaluation of a pharmacist managed anti-coagulation clinic. J. Clin Hosp Pharm 1985; 10: 167-75.
6. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo,RL. Retrospective evaluation of a pharmacist-managed warfarin anti-coagulation clinic. Am J Hosp Pharm 1985; 42: 304-8.
7. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin monitoring service to co-ordinate inpatient and out-patient therapy. Am J Hosp Pharm 1992; 49: 387-94.
8. Dager WE, Branch JM, King JH. Optimisation of in-patient warfarin therapy: impact of daily consultation by a pharmacist managed anti-coagulation service. Ann Pharmacother 2000; 34: 567-72.
9. Patel P, Luckitt J. A pharmacist led service for in-patient anti-coagulation. Thrombus 2002; 6: 9-11.
10. Taylor M, Rhodes S, Bond S et al. An anti-coagulation service in evolution. Thrombus 2001; 5: 6-7.
11. Boddy C. Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci 2001; 23: 31-5.
12. Department of Health. Implementing the European working time directive for doctors in training. HSC 2003/001. London: Department of Health, 3 January 2003.
13. Guidelines on Oral Anticoagulation. Br J Haematol 1998; 101: 374-87.
14. Dobrzwski S. Predicting Warfarin Dosage. J Clin Hosp Pharm 1983; 8: 247-50.